Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago STEM News.
Press releases published on August 19, 2025

Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …

ZenaTech Unveils New Quantum Computing Division to Accelerate Advanced Drone and Defense Capabilities
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …

Champion Safe Co. Welcomes Mountain Pass Safes: Montana’s Rising Leader in Security and Service
Family-owned Mountain Pass Safes …

Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025
RA'ANANA, Israel, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced that a …

NordVPN: August 19 is international VPN day — are you protecting your privacy?
International VPN Day — a timely reminder that your personal data needs serious protection in a world where 345 million records have already been breached this year LONDON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- 2025 is shaping up to be a historic year — for …

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns were raised in the clinical hold notification regarding the BX004 drug candidate Enrollment and …

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black …

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Chris …

New PXM Manifesto Demonstrates Urgency of Leading in the Age of Agentic AI
BOSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Salsify, the leading Product Experience Management (PXM) platform, today announced the publication of "The PXM AI Manifesto," a no-nonsense guide for digital commerce leaders. The manifesto cuts through the AI hype …

Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
SPC-15’s intranasal spray formulation meets safety standards for clinical trial development SARASOTA, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and …

iBio Announces Pricing of $50 Million Public Offering
SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase 71,540, …

SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an Independent Director and Chair of the …

Interact Launches New Features to Expand Its Industry-Leading Employee Experience Platform
MANCHESTER, United Kingdom and NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Interact, the provider of the Employee Experience (EX) Platform that powers the world’s best workplaces, today announced a significant expansion of its platform capabilities with a …

Gaxos Labs Launches Art-Gen, an AI Image and Video Creation Platform Targeting Multi-Billion Dollar Market
Roseland, NJ, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Art-Gen.AI, an AI image and video …

Arvo Partners with UKG to Help SMBs Capture Tax Credits
COLUMBUS, Ohio, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arvo, the financial operations hub purpose-built for small businesses, today announced a technology partnership with UKG, a leading provider of HR, payroll, workforce management, and culture solutions. This …

Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
BOSTON and ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”), …

zSpace Empowers Educators with zKnow™: AI-Powered Assistant Delivers Instant Answers, Saving Teachers Valuable Time
SAN JOSE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) solutions for education, today announced zKnowTM, an intelligent AI assistant that instantly answers educator questions about …

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, …

Epiq and IRIS Partner to Deliver AI Document Capture and Management
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Epiq today announced a strategic partnership with IRIS, a Canon company, to transform how organizations convert documents into actionable knowledge and business insights. IRIS brings advanced AI and machine …

AdOmni Supercharges Ads Platform, Launching AI-Driven Self-Serve Campaigns in Minutes
LAS VEGAS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- AdOmni, the leading AI-powered programmatic Digital-Out-of-Home (DOOH) and video advertising platform, today announced groundbreaking enhancements to its platform that enables self-service DOOH campaigns to be …